Dr. Huang He
Director, Bone Marrow Transplantation Center; Chief Physician; Professor
Where they practice, who they consult.
- First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
- 30+ years in transplantation and cell therapy
- English, Mandarin
What they personally lead.
Training and recognition
Leads one of China's largest CAR-T clinical research programs, with hundreds of patients treated on investigator-initiated trials targeting CD19, BCMA, and dual antigens; senior-author publications in Leukemia, Journal of Hematology and Oncology, and Blood Advances; chair-level roles in the Chinese Society for Cell Therapy and Hematopoietic Stem Cell Transplantation
What to expect
A practical option for patients seeking CAR-T therapy who are not candidates for, or cannot access, an approved commercial product in their home country. Trial eligibility, manufacturing timelines, and safety monitoring (CRS, ICANS) must be discussed before travel.
Check the public record
Look up publications, citations, and academic profile on independent platforms before reaching out.
Results are automated searches and may include other individuals with similar names.
Ask the AI or request a coordinator.
The AI can compare Huang He's background to other specialists in Hangzhou. A coordinator can confirm appointment availability and English-language support.
Information is provided for reference only and may not reflect current conditions. Verify directly with the hospital before making decisions.